Literature DB >> 4803866

Does lithium prevent depressions by suppressing manias?

A Kukopulos, D Reginaldi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4803866     DOI： 10.1159/000467986

Source DB:  PubMed          Journal:  Int Pharmacopsychiatry        ISSN： 0020-8272


× No keyword cloud information.
  5 in total

Review 1.  Memantine: New prospective in bipolar disorder treatment.

Authors:  Giulia Serra; Francesca Demontis; Francesca Serra; Lavinia De Chiara; Andrea Spoto; Paolo Girardi; Giulio Vidotto; Gino Serra
Journal:  World J Psychiatry       Date:  2014-12-22

2.  Transitions: Athanasios Koukopoulos [AθανάσιΟς κΟυκόπΟυλΟς], M.D. (1931-2013).

Authors:  Daniela Reginaldi; Alexia Koukopoulos; Ross J Baldessarini; Gianni L Faedda; Giuseppe Fazzari; Paolo Girardi; Giorgio Kotzalidis; Giovanni Manfredi; Gian Paolo Minnai; Isabella Pacchiarotti; Michele Raja; Gabriele Sani; Gino Serra; Leonardo Tondo; Eduard Vieta
Journal:  Int J Bipolar Disord       Date:  2013-10-08

3.  Free Interval Duration: Clinical Evidence of the Primary Role of Excitement in Bipolar Disorder.

Authors:  Gabriele Sani; Alessio Simonetti; Daniela Reginaldi; Alexia E Koukopoulos; Antonio Del Casale; Giovanni Manfredi; Georgios D Kotzalidis; Paolo Girardi
Journal:  Curr Neuropharmacol       Date:  2017-04       Impact factor: 7.363

Review 4.  Neurobiological Evidence for the Primacy of Mania Hypothesis.

Authors:  Georgios D Kotzalidis; Chiara Rapinesi; Valeria Savoja; Ilaria Cuomo; Alessio Simonetti; Elisa Ambrosi; Isabella Panaccione; Silvia Gubbini; Pietro De Rossi; Lavinia De Chiara; Delfina Janiri; Gabriele Sani; Alexia E Koukopoulos; Giovanni Manfredi; Flavia Napoletano; Matteo Caloro; Lucia Pancheri; Antonella Puzella; Gemma Callovini; Gloria Angeletti; Antonio Del Casale
Journal:  Curr Neuropharmacol       Date:  2017-04       Impact factor: 7.363

5.  EDITORIAL: "The Faces of Mania: The Legacy of Athanasios Koukopoulos".

Authors:  Gabriele Sani; Georgios D Kotzalidis; Paolo Girardi
Journal:  Curr Neuropharmacol       Date:  2017-04       Impact factor: 7.363
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.